Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

IHC HEALTH SERVICES INC

NPI: 1679582944 · TREMONTON, UT 84337 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 08/05/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more

$3.55M
Total Medicaid Paid
46,987
Total Claims
37,854
Beneficiaries
70
Codes Billed
2018-01
First Month
2024-03
Last Month

Provider Details

Authorized OfficialSMITH, DENIS (CFO)
NPI Enumeration Date08/05/2006

Related Entities

Other providers sharing the same authorized official: SMITH, DENIS

ProviderCityStateTotal Paid
IHC HEALTH SERVICES, INC. MURRAY UT $68.77M
IHC HEALTH SERVICES, INC. ST GEORGE UT $65.78M
IHC HEALTH SERVICES INC OGDEN UT $54.08M
IHC HEALTH SERVICES, INC. PROVO UT $44.35M
IHC HEALTH SERVICES INC LOGAN UT $25.34M
IHC HEALTH SERVICES, INC. CEDAR CITY UT $20.40M
IHC HEALTH SERVICES, INC. SALT LAKE CITY UT $19.91M
IHC HEALTH SERVICES, INC. AMERICAN FORK UT $17.19M
IHC HEALTH SERVICES INC RIVERTON UT $15.31M
IHC HEALTH SERVICES INC SANDY UT $11.66M
IHC HEALTH SERVICES, INC. LAYTON UT $11.61M
IHC HEALTH SERVICES, INC. BURLEY ID $5.14M
IHC HEALTH SERVICES INC MURRAY UT $4.64M
IHC HEALTH SERVICES INC ST GEORGE UT $4.35M
IHC HEALTH SERVICES INC HEBER CITY UT $4.31M
IHC HEALTH SERVICES, INC. OREM UT $4.18M
IHC HEALTH SERVICES, INC. RICHFIELD UT $3.87M
IHC HEALTH SERVICES, INC. SPANISH FORK UT $3.49M
IHC HEALTH SERVICES INC PARK CITY UT $2.53M
IHC HEALTH SERVICES, INC. MT PLEASANT UT $2.34M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 6,566 $479K
2019 6,928 $467K
2020 9,171 $715K
2021 12,485 $858K
2022 10,973 $986K
2023 703 $35K
2024 161 $5K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
8888888 Internal/system code - not a standard HCPCS code 7,127 3,941 $2.70M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,745 3,833 $196K
99283 Emergency department visit for the evaluation and management, moderate severity 3,787 3,237 $117K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,076 1,648 $103K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 709 640 $73K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,418 1,248 $70K
99284 Emergency department visit for the evaluation and management, high severity 2,220 1,872 $31K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 842 779 $31K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 360 285 $28K
80050 General health panel 272 245 $25K
96375 Therapeutic injection; each additional sequential IV push 1,323 1,089 $20K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 260 233 $15K
81001 1,933 1,676 $13K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,148 984 $12K
71045 Radiologic examination, chest; single view 721 647 $11K
80053 Comprehensive metabolic panel 4,527 3,700 $11K
71046 Radiologic examination, chest; 2 views 492 440 $11K
87086 Culture, bacterial; quantitative colony count, urine 1,092 987 $9K
87081 374 361 $9K
84443 Thyroid stimulating hormone (TSH) 563 540 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg 840 698 $8K
80048 Basic metabolic panel (calcium, ionized) 98 90 $6K
96361 Intravenous infusion, hydration; each additional hour 737 623 $5K
84702 329 286 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1,511 1,218 $4K
J7120 Ringers lactate infusion, up to 1000 cc 168 144 $3K
74018 82 77 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 49 47 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 189 166 $2K
80061 Lipid panel 370 355 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 79 71 $2K
96376 14 13 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg 43 39 $1K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 943 829 $1K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 28 13 $1K
74177 Computed tomography, abdomen and pelvis; with contrast material 172 161 $1K
87077 13 12 $1K
87186 51 50 $944.69
J2704 Injection, propofol, 10 mg 241 222 $877.71
83880 91 81 $773.96
87631 16 16 $515.25
J1100 Injection, dexamethasone sodium phosphate, 1 mg 89 77 $467.53
85027 13 12 $431.12
83605 1,043 872 $416.16
83036 Hemoglobin; glycosylated (A1C) 126 114 $390.71
86140 525 452 $388.11
84484 451 386 $374.50
83690 1,100 958 $367.94
70450 Computed tomography, head or brain; without contrast material 34 31 $298.85
82607 54 51 $197.01
85610 180 131 $145.40
85379 317 285 $99.30
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 42 40 $59.72
87070 12 12 $48.24
82570 12 12 $32.57
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 505 460 $14.26
J3010 Injection, fentanyl citrate, 0.1 mg 42 32 $5.45
85651 56 49 $3.94
82728 43 37 $0.00
J1170 Injection, hydromorphone, up to 4 mg 68 53 $0.00
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 16 14 $0.00
71275 Computed tomographic angiography, chest, with contrast material 14 13 $0.00
87088 12 12 $0.00
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 18 15 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 12 12 $0.00
83615 37 32 $0.00
84478 19 18 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 17 12 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 61 53 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 16 13 $0.00